4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-20-030431
Chairman sold 40,000 shares at an average $90.59 ($3,623,600)
- Chairman acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
El-Hibri Fuad · Chairman
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 1 in the form | +20,000 | $26.45 | $529,000 | 1,143,988 | D |
| 2020-11-02 | Sale : show line 2 in the form | −20,000 | $90.44 | $1,808,800 | 1,123,988 | D |
| 2020-11-03 | Exercise or conversion : show line 3 in the form | +20,000 | $26.45 | $529,000 | 1,143,988 | D |
| 2020-11-03 | Sale : show line 4 in the form | −20,000 | $90.74 | $1,814,800 | 1,123,988 | D |
| Open-market sales · 40,000 sh · avg $90.59 · $3,623,600 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) | −20,000 | 59,391 | D |
| 2020-11-03 | Exercise or conversion : show line 6 in the form Stock Options (Right to Buy) | −20,000 | 39,391 | D |
Loading xslF345X03/doc4.xml…